Project Details
Description
Leukemia & Lymphoma Society PedAL Initiative_LLSAMABV-AMLABV: A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML
| Status | Active |
|---|---|
| Effective start/end date | 6/30/23 → 6/30/27 |
Funding
- LLS PEDAL INITIATIVE, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.